Results 1 to 10 of about 11,777 (217)

Nitroglycerin as a Hypotensive Drug during General Anesthesia [PDF]

open access: bronzeSurvey of Anesthesiology, 1978
Circulatory variables and arterial partial pressure for oxygen (PaO2) were compared in 91 anesthetized patients who received infusions of either nitroglycerin (TNG) or nitroprusside (SNP) to induce hypotension for the purpose of decreasing intraoperative blood loss.
N. R. Fahmy
openaire   +3 more sources

Repurposing Drugs in Oncology (ReDO)—nitroglycerin as an anti-cancer agent [PDF]

open access: goldecancermedicalscience, 2015
Nitroglycerin (NTG), a drug that has been in clinical use for more than a century, has a range of actions which make it of particular interest in an oncological setting. It is generally accepted that the main mechanism of action of NTG is via the production of nitric oxide (NO), which improves cardiac oxygenation via multiple mechanisms including ...
Sukhatme, Vidula   +4 more
openaire   +5 more sources

Comparative Efficacies of Antimigraine Drugs Using Nitroglycerin Induced Migraine Rats Model

open access: diamondJournal of Pharmaceutical Research International, 2021
Aim: The migraine pathology is still not explained effectively. There is a common relationship between anxiety, depression, and migraine. So the aim of the study to illustrate effectively the behavioural and biomarker changes in the migraine condition. Methods: Nitroglycerin (NTG) induced migraine rats model was used the present study.
V. Parthasarathy, Anson S. Maroky
openaire   +3 more sources

Enhanced delivery of macromolecular antitumor drugs to tumors by nitroglycerin application [PDF]

open access: greenCancer Science, 2009
Dose regimens of anticancer agents are usually designed on the basis of the maximum tolerable drug doses, and toxicity prevents drug usage at higher doses, even though the drugs may be more effective at the higher doses. We previously studied macromolecular anticancer drugs, i.e.
Takahiro, Seki   +2 more
openaire   +4 more sources

Topical Nitroglycerin for Osteoporosis: Old Drug New Application

open access: closedJournal of South Asian Federation of Obstetrics and Gynaecology, 2016
ABSTRACTOsteoporosis is a progressive bone disease characterized by a decrease in the bone mass and density, which can lead to an increased risk of fracture. Multiple treatments have been formulated for it like calcium, vitamin D supplements, bisphosphonates, raloxifene, hormone replacement therapies, teriparatide and calcitonin.
Ayush Agarwal   +2 more
openaire   +2 more sources

Shear Stress Targeted Delivery of Nitroglycerin to Brain Collaterals Improves Ischaemic Stroke Outcome [PDF]

open access: yesAdvanced Science
In patients with ischaemic stroke, retrograde perfusion of the penumbra by leptomeningeal collateral vessels (LMCs) strongly predicts clinical outcome, suggesting that enhancing LMC flow can offer a novel therapeutic approach.
Magdalena Litman   +21 more
doaj   +2 more sources

Sublingual and Buccal Delivery: A Historical and Scientific Prescriptive [PDF]

open access: yesPharmaceutics
In this review, our intention was to shed some light on the history of sublingual and buccal delivery over the past 75 years. By searching the query sublingual and buccal, we noticed four steady growth periods in the number of publications between 1950 ...
Sina Bahraminejad, Hassan Almoazen
doaj   +2 more sources

Integrated ATAC-seq and RNA-seq analysis identifies Grid2 and Reln as potential regulatory genes in migraine pathophysiology [PDF]

open access: yesThe Journal of Headache and Pain
Background Migraine pathophysiology involves epigenetic mechanisms, but key molecular regulators remain poorly defined. This study aimed to elucidate these mechanisms using a comprehensive multi-omics approach. Methods We established a nitroglycerin (NTG)
Fei Wang   +4 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy